Next-Generation Sequencing Market to Reach US$ 31,411.3 Mn, Introduction of Rapid Sequencing Technologies Drives the Market
                     Title :  Next-Generation Sequencing Market to Reach US$ 31,411.3 Mn, Introduction of 
Rapid Sequencing Technologies Drives the Market
Description :  Next-Generation Sequencing Market to Rise at 22.2% CAGR, Rising Adoption
of NGS Platforms for the Treatment of Rare Disorders Boosts Growth: Fortune Business 
Insights
Content :
The Global Next-Generation Sequencing Market is forecast to exhibit a remarkable CAGR as
the next-generation sequencing platform allows effective sequencing of  millions of  DNA
molecules. Fortune Business Insights in a new report, titled“ Next-Generation Sequencing:
Global Market Analysis, Insights and Forecast, 2019-2026” offers a detailed analysis of the
competitive  landscape  and  market  dynamics.  As  per  the  report,  the  global  market  is
expected to rise at a ferocious CAGR of 22.2% between 2018 and 2026. In 2018, the market
was worth US$ 6,335.2 Mn and the market will be a howling success as it is projected to
reach  US$  31,411.3  Mn  by  2026.   The  demand  for  next-generation  sequencing
methodologies is increasing rapidly across several applications such as diagnostics, clinical
research among others.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this 
health crisis has brought an unprecedented impact on businesses across industries. 
However, this too shall pass. Rising support from governments and several companies can 
help in the fight against this highly contagious disease. There are some industries that are 
struggling and some are thriving. Overall, almost every sector is anticipated to be impacted 
by the pandemic. 
We are taking continuous efforts to help your business sustain and grow during COVID-19 
pandemics. Based on our experience and expertise, we will offer you an impact analysis of 
corona virus outbreak across industries to help you prepare for the future. 
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For  More  Information : https://www.fortunebusinessinsights.com/industry-reports/next-
generation-sequencing-ngs-market-101000
Adapative  Technologies  developed  a  next-generation  sequencing  diagnostic  test  called
ClonoSEQ  for  patients  suffering  fromacute  lymphoblastic  leukemia  or  ALL  and  minimal
residual disease or MRD. The test received FDA approval in September 2018, which in turn,
contributes to the growth of the market in North America. 
Increasing  investments  in  precision  medicine  and  a  growing  number  of  strategic
collaborations are driving the market in Europe. Driven by these factors, the market in this
region is expected to expand in the forecast period.  Apart  from these two regions, Asia
Pacific is expected to expand at a remarkable growth on account of rising geriatric 
Demand for Next-Generation Sequencing Services to Rising at a High Pace
Next-generation sequencing products encompass instruments, consumables, and software.
According to the findings from the report, the next-generation sequencing product segment
is anticipated to lead the market over the forecast period. This is ascribable to some primary
factors such as new product launches, high usage of consumables, and easy availability.
Apart from next-generation sequencing products, next-generation sequencing services are
expected to grow at a higher CAGR during the forecast period. 
The need for novel platforms regarding advancements in bioinformatics and fast DNA data
interpretation are paving the way for start-ups, especially for next-generation sequencing
services. With the introduction of next-generation sequencing, the cost of sequencing has
reduced over the years.
More Trending Topics from Fortune Business Insights : 
Medical Imaging Equipment Market , Share, Growth, Sales and Drivers Analysis Research 
Report 2026
Medical Imaging Equipment Market to Value US$ 44,077.7 Mn at CAGR of 4.6% by 2025 | 
Exclusive Report by Fortune Business Insights